OA11165A - Process for preparation of pyrazoloÄ4,3-dÜpyeimidin-7-ones and intermediates thereof - Google Patents

Process for preparation of pyrazoloÄ4,3-dÜpyeimidin-7-ones and intermediates thereof Download PDF

Info

Publication number
OA11165A
OA11165A OA9900224A OA9900224A OA11165A OA 11165 A OA11165 A OA 11165A OA 9900224 A OA9900224 A OA 9900224A OA 9900224 A OA9900224 A OA 9900224A OA 11165 A OA11165 A OA 11165A
Authority
OA
OAPI
Prior art keywords
compound
formula
tertiary
alkanol
cycloalkyl
Prior art date
Application number
OA9900224A
Other languages
English (en)
Inventor
Peter James Dunn
Philip Charles Levett
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11165(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of OA11165A publication Critical patent/OA11165A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (1)

  1. 011165 -27- CLAIMS 1) A process for the préparation of a compound of formulae (IA) and (IB)
    O2S. O2S. 'N
    NCHc (IA) 'N (IB) NCH2CH3 comprising reacting a compound of formula (IIA) and (IIB) respectively in thepresence of "OR, wherein R in the case of formation of compound (IA) is CH2CH3and R in the case of formation of compound (IB) is CH2CH2CH3, where X is aleaving group: -28- 011165
    2) A process as claimed in claim 1 wherein X is selected from the groupconsisting of arylsuiphonyloxy, C1-C4 alkylsulphonyloxy, nitro or halosubstituted benzenesulphonyloxy, C1-C4 perfluoroalkylsulphonyloxy,optionally substituted aroyloxy, C1-C4 perfluoroalkanoyloxy, C1-C4alkanoyloxy, halo; diazonium; C1-C4 primary and secondary alkoxy, oxonium,perchloryloxy, quatenaryammonium C1-C4 alkylsulphonuloxy,halosulphonyloxy, halonium and diarylsulphonylamino. 3) A process as claimed in claim 2 wherein X is a halo or methoxy. 4) A process as claimed in claim 3 wherein X is fluoro, chloro or methoxy. 5) A process as claimed in claim 4 wherein X is fluoro or chloro. 6) A process as claimed in any one of the preceeding daims wherein OR is présent with an auxiliary base. 7) A process as claimed in claim 6 wherein the auxiliary base is selected fromthe group consisting of sterically hindered base , métal salts of 1-methylpiperazine (especially for compound IA), 1-ethylpiperazine (especially forcompound IB), morpholine ,a métal hydride, métal oxide, métal carbonateand métal bicarbonate. 8) A process as claimed in claim 7 wherein the sterically hindered base is amétal sait of a sterically hindered alcohol or amine. 9) A process as claimed in claim 8 wherein the métal sait of a stericallyhindered alcohol or amine is selected from the group consisting of a 011165 -29- secondary or tertiary C4-C12 alkanol, a C3-C12 cycloalkanol and a secondary ortertiary (C3-C3 cycloalkyl)Ci-C6 alkanol, a N-(secondary or tertiary C3-C6 alkyl)-N-(primary, secondary or tertiary Ο3-Οθ alkyl)amine, a N-(C3-C8 cycloalkyl)-N-(primary, secondary or tertiary O3-C6 alkyl)amine, a di(C3-C8 cycloalkyl)amine 5 or hexamethyldisilazane 1,5-diazabicyclo[4,3,0]non-5-ene 1,8- diazabicyclo[5,4,0]undec-7-ene and tertiary amines such as triethylamine. 10) A process as claimed in daims 9 wherein the auxiliary base is a métal sait ofa tertiary alkanol. 11) A process as claimed in any one of the preceding daims wherein the réaction 10 is carried out in an inert solvent or ROH or a mixture of both. 12) A process as claimed in daim 11 wherein the solvent is selected from the group consisting of éthanol (for IA), n-propanol (for IB), a secondary ortertiary C4-C12 alkanol, a C3-Ci2 cycloalkanol, a tertiary C4-C12 cycloalkanol, asecondary or tertiary (C3-C7 cycloalkyl)C2-C6 alkanol, a C3-C9 alkanone, 1,2- 15 dimethoxyethane, 1,2-diethoxyethane, diglyme, tetrahydrofuran, 1,4-dioxan, toluene, xylene, chlorobenzene, 1,2-dichlorobenzene, acetonitrile, dimethylsulphoxide, sulpholane, dimethylformamide, N-methylpyrrolidin-2-one,pyridine, and mixtures thereof. 13) A process as claimed in daim 12 wherein the solvent is selected from the 20 group consisting of éthanol (for IA), n-propanol (for IB), a tertiary C4-Ci2 alkanol, a tertiary C4-Ci2 cycloalkanol, a tertiary (C3-C7 cycloalkyl)C2-C6alkanol, a C3-C9 alkanone, 1,2-dimethoxyethane, 1,2-diethoxyethane,diglyme, tetrahydrofuran, 1,4-dioxan, toluene, xylene, chlorobenzene, 1,2-dichlorobenzene, acetonitrile, sulpholane, dimethylformamide, N- 25 methylpyrrolidin-2-one, pyridine, and mixtures thereof. 14) A process as claimed in daim 13 wherein the solvent is éthanol (for IA) orpropanol (for IB). 15) A process for the préparation of a compound of formula (IA) and (IB)according to any one of the preceding daims comprising reacting a 30 compound of formula (IIA) and (IlB) respectively with ZOR , or with ROH and 011165 -30- an auxiliary base as defined hereinbefore or with ZOR and an auxiliary base,wherein ZOR is a sait of OR and Z is a cation. 16) A process as claimed in claim 15 wherein compound (IA) is formed byreaction of compound (IlA): 5 a) with éthanol and auxiliary base, optionally in an inert solvent; or b) with ZOEt and an auxiliary base in éthanol or an inert solvent or both; or) c) with ZOEt and éthanol or an inert solvent or both. 17) A process as claimed in claim 15 wherein compound (IB) is formed byreaction of compound (IIB): 10 d) with propanol and auxiliary base, optionally in an inert solvent (as defined herebefore); or e) with ZOPr and an auxiliary base, in propanol or an inert solvent or both; or f) with ZOPr, and propanol or an inert solvent or both. 18) A process as claimed in any one of the preceding daims wherein the 15 compound of formula (HA) is prepared by coupling a compound of formula (VI IA)
    -31- 011165 with a compound of formula (IXA)
    (IXA) and a compound of formula (IIB) is prepared by coupling a compound of formula(VIIB)
    (VIIB) with a compound of formula (IXB)
    -32- 011165 19) A process as claimed in claim 18 wherein a compound of the formula (VllA) isformed by coupling a compound of formula (VIA) with N-methylpiperazine
    (VIA) and a compound of formula (VHB) is formed by coupling a compound of formula(VIA) with N-ethylpiperazine. 20) A compound of formula(IIA) and (IIB):
    wherein X is as defined in any one of daims 1 to 5. 21) A compound of formula (IlIA) and (IIIB): -33- 011165
    (HIA)
    wherein X is as defined in anyone of daims 1 to 5. 22) A compound of formula (VIIA) and (VIIB)
    (VIIB) wherein X is as defined in anyone of daims 1 to 5. 23) A compound as claimed in any of daims 20 to 22 herein X is selected from thegroup consisting of fluoro, chloro and methoxy.
OA9900224A 1998-10-12 1999-10-08 Process for preparation of pyrazoloÄ4,3-dÜpyeimidin-7-ones and intermediates thereof OA11165A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
OA11165A true OA11165A (en) 2003-04-22

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900224A OA11165A (en) 1998-10-12 1999-10-08 Process for preparation of pyrazoloÄ4,3-dÜpyeimidin-7-ones and intermediates thereof

Country Status (49)

Country Link
US (3) US6207829B1 (fr)
EP (1) EP0994115B1 (fr)
JP (1) JP3721021B2 (fr)
KR (1) KR100380954B1 (fr)
CN (2) CN1473831A (fr)
AP (1) AP1233A (fr)
AR (1) AR019244A1 (fr)
AT (1) ATE290003T1 (fr)
AU (1) AU756463B2 (fr)
BG (1) BG63205B1 (fr)
BR (1) BR9905092A (fr)
CA (1) CA2285733C (fr)
CO (1) CO5150214A1 (fr)
CR (1) CR6118A (fr)
CU (1) CU22928A3 (fr)
CZ (1) CZ296816B6 (fr)
DE (1) DE69923906T2 (fr)
DK (1) DK0994115T3 (fr)
DZ (1) DZ2912A1 (fr)
EA (1) EA003774B1 (fr)
EE (1) EE04192B1 (fr)
EG (1) EG22630A (fr)
ES (1) ES2237049T3 (fr)
GB (1) GB9822238D0 (fr)
GE (1) GEP20022700B (fr)
GT (1) GT199900172A (fr)
HK (1) HK1027559A1 (fr)
HR (1) HRP990318B1 (fr)
HU (1) HU226162B1 (fr)
ID (1) ID23351A (fr)
IL (11) IL152928A (fr)
IS (1) IS1951B (fr)
MA (1) MA25007A1 (fr)
MY (1) MY124620A (fr)
NO (1) NO313700B1 (fr)
OA (1) OA11165A (fr)
PE (1) PE20001086A1 (fr)
PL (1) PL198150B1 (fr)
PT (1) PT994115E (fr)
RS (1) RS49762B (fr)
SG (1) SG118060A1 (fr)
SI (1) SI0994115T1 (fr)
SK (1) SK285215B6 (fr)
TN (1) TNSN99189A1 (fr)
TR (1) TR199902541A2 (fr)
TW (1) TW589314B (fr)
UA (1) UA66787C2 (fr)
UY (1) UY25750A1 (fr)
ZA (1) ZA996412B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5204800A (en) * 1999-06-21 2001-01-09 Biochemical Pharmaceutical Factory of Zhuhai Sez, The Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
AP2001002194A0 (en) * 2000-06-22 2002-12-21 Pfizer Novel process for the preparation of pyrazolopyrimidinones.
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
EP1176142A1 (fr) * 2000-07-28 2002-01-30 Pfizer Inc. Procédé pour la préparation de pyrazoles
EP1176147A1 (fr) * 2000-07-28 2002-01-30 Pfizer Limited Procédé de préparation de pyrazolo[4,3-d]pyrimidin-7-ones et de leurs intermédiaires
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
JP4554931B2 (ja) 2001-12-20 2010-09-29 メルク セローノ ソシエテ アノニム プロスタグランジン調節物質としてのピロリジン誘導体
US6908923B2 (en) 2001-12-21 2005-06-21 Cytokinetics, Inc. Compositions and methods for treating heart failure
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (fr) * 2003-02-11 2004-08-26 Pfizer Limited Compose d'hemi-citrate de sildenafil hydrate et anhydre
JP4969238B2 (ja) 2003-03-27 2012-07-04 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (fr) * 2006-06-05 2010-10-27 Matrix Lab Ltd Nouveau procédé de préparation du citrate de sildénafil
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (fr) 2016-04-02 2017-10-05 N4 Pharma Uk Limited Nouvelles formes pharmaceutiques du sildénafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
US6723719B1 (en) * 1997-04-25 2004-04-20 Pfizer Inc Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction

Also Published As

Publication number Publication date
AP1233A (en) 2003-12-18
AU5358199A (en) 2000-04-13
EP0994115A3 (fr) 2000-05-24
CN1255497A (zh) 2000-06-07
PL198150B1 (pl) 2008-05-30
US6207829B1 (en) 2001-03-27
TNSN99189A1 (fr) 2005-11-10
EA199900822A2 (ru) 2000-04-24
IS1951B (is) 2004-10-13
SK138599A3 (en) 2000-05-16
DK0994115T3 (da) 2005-06-20
BG103794A (en) 2000-09-29
PT994115E (pt) 2005-06-30
IL132273A0 (en) 2001-03-19
IL152924A (en) 2004-02-19
ATE290003T1 (de) 2005-03-15
US20030069422A1 (en) 2003-04-10
DZ2912A1 (fr) 2004-03-01
NO313700B1 (no) 2002-11-18
IL152926A0 (en) 2003-06-24
EG22630A (en) 2003-05-31
CN1473831A (zh) 2004-02-11
KR20000028987A (ko) 2000-05-25
CO5150214A1 (es) 2002-04-29
CR6118A (es) 2005-09-16
IS5209A (is) 2000-04-13
MA25007A1 (fr) 2000-07-01
ZA996412B (en) 2001-04-11
EE04192B1 (et) 2003-12-15
IL152928A (en) 2007-07-04
HU226162B1 (en) 2008-05-28
IL152926A (en) 2004-02-19
US20010009962A1 (en) 2001-07-26
PE20001086A1 (es) 2000-10-18
ID23351A (id) 2000-04-13
CZ353299A3 (cs) 2000-05-17
NO994943D0 (no) 1999-10-11
GT199900172A (es) 2001-03-28
RS49762B (sr) 2008-04-04
HU9903469D0 (en) 1999-12-28
YU48999A (sh) 2002-06-19
ES2237049T3 (es) 2005-07-16
CA2285733C (fr) 2004-08-24
GEP20022700B (en) 2002-05-27
BG63205B1 (bg) 2001-06-29
DE69923906T2 (de) 2006-04-06
HUP9903469A2 (hu) 2000-08-28
IL152927A (en) 2004-06-01
NO994943L (no) 2000-04-13
HRP990318B1 (en) 2004-06-30
DE69923906D1 (de) 2005-04-07
SK285215B6 (sk) 2006-09-07
TW589314B (en) 2004-06-01
EE9900507A (et) 2000-06-15
IL152923A0 (en) 2003-06-24
EA003774B1 (ru) 2003-08-28
JP2000119273A (ja) 2000-04-25
IL152927A0 (en) 2003-06-24
EA199900822A3 (ru) 2000-08-28
AP9901672A0 (en) 1999-12-31
JP3721021B2 (ja) 2005-11-30
SG118060A1 (en) 2006-01-27
CN1207295C (zh) 2005-06-22
IL152923A (en) 2004-02-08
IL152924A0 (en) 2003-06-24
TR199902541A2 (xx) 2000-07-21
CZ296816B6 (cs) 2006-06-14
PL335959A1 (en) 2000-04-25
UA66787C2 (en) 2004-06-15
CA2285733A1 (fr) 2000-04-12
AR019244A1 (es) 2001-12-26
BR9905092A (pt) 2000-08-08
HK1027559A1 (en) 2001-01-19
IL132273A (en) 2004-06-20
SI0994115T1 (fr) 2005-08-31
KR100380954B1 (ko) 2003-04-21
HRP990318A2 (en) 2000-06-30
EP0994115B1 (fr) 2005-03-02
HUP9903469A3 (en) 2000-10-30
EP0994115A2 (fr) 2000-04-19
AU756463B2 (en) 2003-01-16
MY124620A (en) 2006-06-30
GB9822238D0 (en) 1998-12-09
UY25750A1 (es) 2001-08-27
IL152928A0 (en) 2003-06-24
CU22928A3 (es) 2004-02-20

Similar Documents

Publication Publication Date Title
OA11165A (en) Process for preparation of pyrazoloÄ4,3-dÜpyeimidin-7-ones and intermediates thereof
EP0812845B1 (fr) Procédé pour la préparation de sildenafil
US5239077A (en) Highly pure amidoximes
OA11495A (en) Process for the preparation of pyrazoloÄ4,3-dÜpyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof.
US3862184A (en) N-substituted-1-(arylsulfinyl and arylsulfonyl)methanesulfonamides
US3959298A (en) Process for preparing triacetonamine
MXPA99009326A (en) Procedure for the preparation of pirazolo [4,3-d] pyrimidin-7-onas and its intermed
JP4467684B2 (ja) ピリジン誘導体の製造方法
JPS61134378A (ja) ピリミジン誘導体の製法